Bayer could be on the brink of settling more than 75,000 lawsuits over claims its Roundup weed killer caused users to develop cancer.
Bayer had disclosed during its third-quarter report that it faced 42,700 Roundup lawsuits. On Jan. 16, Ken Feinberg, who is serving as a mediator for Bayer, told Bloomberg that since then, the number of cases has surged to between 75,000 and 85,000. “Maybe more,” he said.
Bayer spokesman Chris Loder said that Feinberg’s estimate is purely speculative and includes “potential plaintiffs.” The real number “remains significantly below 50,000.”
Either way, Feinberg said he was “cautiously optimistic” that Bayer could reach a comprehensive deal with plaintiffs within weeks.
Bayer purchased Monsanto for about $62 billion in 2018, just before the first Roundup case went to trial. Since then, three Roundup trials have been held in California, all of which resulted in multi-million-dollar verdicts for the plaintiffs. Bayer is appealing all of them.
In December, Bayer agreed to postpone some upcoming Roundup trials and enter into mediation with a goal of a global settlement.
People suing Bayer allege that exposure to glyphosate, the active ingredient in Roundup, can cause non-Hodgkin’s lymphoma, and that Bayer – and Monsanto before it — was aware of the dangers the chemical posed but refused to warn consumers. In 2015, the World Health Organization’s International Agency for Research on Cancer classified glyphosate as a probable carcinogen based on studies of farmers exposed to glyphosate who developed non-Hodgkin’s lymphoma.
Beasley Allen lawyers are currently representing clients who have been exposed to Roundup and developed non-Hodgkin’s lymphoma. Our Roundup Litigation Team would welcome the opportunity to speak with you regarding a potential claim. For more information, contact one of the members of the Roundup Litigation Team: John Tomlinson (who heads up the team), Michael Dunphy, Danielle Ingram or Rhon Jones, all lawyers in our Toxic Torts Section.